Skip to content
10-Q/A

Quarterly Report

CTT PHARMACEUTICAL HOLDINGS, INC. CTTH

0001553350-15-001205

← back to feed
Filed
Nov 12, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Nov 4, 2015 21.35M sh
Operating Cash Flow Q1 2015 · Mar 31, 2015 −$39.65K
Operating Cash Flow restated Q1 2015 · Mar 31, 2014 −$330
Cash And Equivalents Q1 2015 · Mar 31, 2015 $73.45K
Cash And Equivalents Q1 2015 · Dec 31, 2014 $81.18K
Cash And Equivalents restated Q1 2015 · Mar 31, 2014 $4.55K
Stockholders Equity restated Q1 2015 · Mar 31, 2015 $1.21M
Stockholders Equity restated Q1 2015 · Dec 31, 2014 $1.49M
Stockholders Equity restated Q1 2015 · Dec 31, 2013 −$29.32K
Stockholders Equity restated Q1 2015 · Dec 31, 2012 −$20K
Total Liabilities restated Q1 2015 · Mar 31, 2015 $211.7K
Total Liabilities restated Q1 2015 · Dec 31, 2014 $169.49K
Current Assets Q1 2015 · Mar 31, 2015 $1.04M
Current Assets Q1 2015 · Dec 31, 2014 $1.05M
Total Assets Q1 2015 · Mar 31, 2015 $1.42M
Total Assets Q1 2015 · Dec 31, 2014 $1.66M
Sga Expense Q1 2015 · Mar 31, 2015 $34.88K
Sga Expense restated Q1 2015 · Mar 31, 2014 $907
Net Income Q1 2015 · Mar 31, 2015 −$337.05K
Net Income restated Q1 2015 · Dec 31, 2014 −$672.16K
Net Income restated Q1 2015 · Mar 31, 2014 −$1.67K
Net Income Q1 2015 · Dec 31, 2013 −$18.91K
Operating Income Q1 2015 · Mar 31, 2015 −$337.05K
Operating Income restated Q1 2015 · Mar 31, 2014 −$1.67K